NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required)

National Institutes of Health

Federal funding opportunity PAR-25-025 published by National Institutes of Health. Review the official synopsis for eligibility, award terms, and application requirements.